Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy

被引：0
|
作者：
Altini, M. [1 ]
Massa, I. [1 ]
Balzi, W. [1 ]
Gentili, N. [1 ]
Foca, F. [1 ]
Danesi, V. [1 ]
Manunta, S. [1 ]
Ejzykowicz, F. [2 ]
Chandwani, S. [3 ]
Burgio, M. [1 ]
Cravero, P. [1 ]
Verlicchi, A. [1 ]
Bronte, G. [1 ]
Crino, L. [1 ]
Delmonte, A. [1 ]
机构：
[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumor Irst, Meldola, Italy
[2] Merck & Co Inc, Oncol Prod Line, Core, Kenilworth, NJ USA
[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
treatment pattern; real-world study; Outcomes;
D O I：
10.1016/j.jtho.2019.08.2369
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.16-04
引用
收藏
页码：S1065 / S1066
页数：2
相关论文
共 50 条
  • [31] Real-world outcomes for metastatic non-small cell lung cancer patients treated with checkpoint inhibitor immunotherapy in Canada
    Yusuf, Dimas
    Ko, Jenny J.
    Cho, Hyokeun
    Sheremeto, Corey
    Wang, Ying
    Juergens, Rosalyn A.
    Ellis, Peter Michael
    Billawala, Alkarim
    Kay, Amin
    Kulkarni, Swati
    Elfiki, Tarek A.
    Gupta, Rasna
    Naccarato, Krista
    Pennetti, Alex
    Patel, Devalben
    Smith, Elliot Charles
    Walton, Ryan
    Hurry, Manjusha
    Liu, Geoffrey
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [32] Real-world costs and outcomes associated with biomarker testing by comprehensive genomic profiling (CGP) and non-CGP approaches among patients with metastatic non-small cell lung cancer (mNSCLC)
    Byfield, Stacey DaCosta
    Bapat, Bela
    Becker, Laura
    Reyes, Carolina
    Chatzitheofilou, Ismini
    Hostin, Damon
    Schroeder, Brock
    Fox, John Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Real-world treatment outcomes with brigatinib in patients with pretreated ALK plus metastatic non-small cell lung cancer
    Popat, Sanjay
    Brustugun, Odd Terje
    Cadranel, Jacques
    Felip, Enriqueta
    Garassino, Marina Chiara
    Griesinger, Frank
    Helland, Aslaug
    Hochmair, Maximilian
    Perol, Maurice
    Bent-Ennakhil, Nawal
    Kruhl, Christian
    Novello, Silvia
    LUNG CANCER, 2021, 157 : 9 - 16
  • [34] Association of early tumor growth rate and survival outcomes in first-line metastatic non-small cell lung cancer (mNSCLC).
    Fojo, Antonio Tito
    Brown, Kevin
    Grootendorst, Diederik J.
    Kotapati, Srividya
    Fronheiser, Matthew
    Tran, Phuong
    Rizzo, Jasmine I.
    Leung, David
    Zhao, Binsheng
    Schwartz, Lawrence Howard
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
    Wu, Junqi
    Hou, Likun
    Zhao, Yue
    Yu, Xin
    Xu, Long
    Ning, Ye
    Deng, Jiajun
    Sun, Ke
    Zhang, Jie
    Wu, Chunyan
    Zhu, Yuming
    Zhao, Deping
    She, Yunlang
    Su, Chunxia
    Chen, Chang
    Haoran, E.
    LUNG CANCER, 2022, 165 : 115 - 123
  • [36] Outcomes in patients with metastatic non-small cell lung cancer (mNSCLC) with brain metastases treated with pembrolizumab-based therapy.
    Sun, Lova
    Davis, Christiana
    Marmarelis, Melina Elpi
    Jeffries, Seth
    Sulyok, Lydia Frenzel
    Hwang, Wei-Ting
    Singh, Aditi Puri
    Berman, Abigail T.
    Feigenberg, Steven J.
    Levin, William C.
    Bauml, Joshua
    Ciunci, Christine Agnes
    Cohen, Roger B.
    Langer, Corey J.
    Aggarwal, Charu
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Real-world biomarker testing trends in metastatic non-small cell lung cancer (NSCLC).
    Clinton, Natasha
    Patel, Manish R.
    Ayars, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18728 - E18728
  • [38] Influence of antibiotic therapy (ATB) on oncological outcomes of metastatic non-small cell lung cancer (mNSCLC) patients treated with chemoimmunotherapy (CIT).
    Clark, James
    Ricciuti, Biagio
    Bolina, Anita
    Venkatraman, Deepti
    Newsom-Davis, Thomas
    Ottaviani, Diego
    Lee, Karla
    Awad, Mark M.
    Pinato, David James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Keeping it real: implications of real-world treatment outcomes for first-line immunotherapy in metastatic non-small cell lung cancer
    Hsu, Grace G.
    MacKay, Eric
    Scheuer, Nicolas
    Ramagopalan, Sreeram, V
    IMMUNOTHERAPY, 2021, 13 (18) : 1453 - 1456
  • [40] Blood Cell Count Ratios at Diagnosis as Prognostic Markers in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)
    Ricardo, Eliza
    Boneti, Bianca
    Ribeiro, Taynan
    De Moraes, Rafael
    Freitas, Helano
    Da Costa, Alexandre
    Andrade, Victor
    De Lime, Vladmir Cordeiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S970 - S971
12345